There is loss of expression of S100A8 and S100A9 in oesophageal squamous carcinoma
Main Authors: | Clarke, L, Rehman, I, Leiblich, A, Bury, J, Ackroyd, R, Stoddard, C, Wyman, A, Harrison, R, Hamdy, F, Cross, S |
---|---|
Format: | Conference item |
Published: |
2005
|
Similar Items
-
Tissue microarray immunohistochemistry for S100A2, S100A4, S100A6, S100A8, S100A9, S100B and annexin I with unsupervised cluster analysis produces a useful classification of oesophageal cancers
by: Clarke, L, et al.
Published: (2005) -
Expression of S100A2, S100A4, S100A6 and S100A7 in oesophageal cancers follows the pattern of expression in the tissues from which they are derived and does not show any significant association with any other clinicopathological parameters
by: Clarke, L, et al.
Published: (2005) -
S100A9 protein is overexpressed in human breast and squamous cell cancers
by: Cross, S, et al.
Published: (2004) -
Expression of beta-dystroglycan is lost in squamous cell and adenocarcinomas of the oesophagus and this loss is significantly related to increasing tumour stage
by: Parbery-Clark, C, et al.
Published: (2005) -
S100A8 protein is expressed in neutrophils, macrophages, some breast cancers and some squamous cell cancers
by: Cross, S, et al.
Published: (2004)